can you stop glp 1 cold turkey Coming Off Ozempic Cold Turkey: Risks and Safe Discontinuation – The grim reality when you
Description
Consultings Executive Insights will explore how payers should strategize their approach to glucagon-like peptide-1 agonists (GLP-1s) as they weigh rising consumer demand and increasing pharma supply with recognition of longer-term return on investment (ROI) opportunity
#GLP1 #EmployeeBenefits #BenefitsBroker #SelfFunded #HealthcareROI #emed To view or add a comment, sign in Most organizations experience market pressure one issue at a time
Other head-to-head trials added clinical momentum to the obesity space throughout 2025
[DOI] [PubMed] [Google Scholar] 25.Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM
